$LAZ

Lazard (NYSE: LAZ) holder lines up multimillion-dollar stock sale

Lazard (NYSE: LAZ) has a notice of proposed sale under Rule 144 for 125,000 shares of its common stock, valued at $5.44M, held for Peter Richard Orszag. The shares are set to vest on August 23, 2026, with the sale planned for August 25, 2026, through Fidelity Brokerage Services LLC. The shares were received as compensation.

Original reporting
Published Aug 25, 2026, 8:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 11:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$LAZ
Neutral
medium confidence
Mentioned
$LAZ
Relevance
5/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$LAZNeutralLow
01

Why it matters

The disclosed sale adds 0.11% of Lazard's outstanding shares to the market, a modest dilution.

02

Market read

A small but notable insider sale that could create short‑term selling pressure.

03

What to watch

Potential concurrent insider transactions or broader market moves could amplify the effect.

Relevance 5/10Novelty 6/10Timing: sale scheduled for Aug 25 2026

Background

Form 144 filings are required for insiders to sell restricted shares, signaling upcoming supply.

Company-level read

Ticker impact

$LAZNeutralMedium confidence
Context

Form 144 filing discloses a planned sale of 125,000 Lazard shares worth $5.44 M, the first public notice of this insider transaction.

Expected impact

minor downward pressure around the sale date

Evidence & confidence

The block size is relatively small for a mid‑cap, but the timing of a restricted‑stock release may add short‑term sell pressure.

Market effects

Minimal impact on financial services sector; only a modest increase in Lazard float.

None

Low

Counterpoint

The sale may be absorbed without price impact if market liquidity is sufficient.

Key entities

  • Peter Richard Orszag

    Beneficiary of the restricted‑stock vesting and upcoming sale.

  • Fidelity Brokerage Services LLC

    Designated attorney‑in‑fact handling the transaction.

Related articles

$LAZMedAI 8/10

Lazard Stock Plunges 14% in 6 Months: Buy the Dip or Cut Your Losses?

Lazard Inc. (LAZ) stock has fallen 14.1% in six months, underperforming peers like Virtu Financial (VIRT) and Jefferies Financial (JEF). Weak earnings, high costs, and macroeconomic uncertainty weigh on its outlook. Analysts revised 2026 earnings down 10.6%, though 2027 estimates show an 83.6% increase. The company's valuation is high, with a P/B ratio of 5.3X. Management targets long-term growth but near-term challenges persist.

$LAZMed

How Lazard’s (LAZ) Swiss Investment Banking Hire Will Impact DACH Advisory Ambitions

Lazard (LAZ) appointed Dr. Marco Superina as head of investment banking for Switzerland, focusing on M&A and capital solutions. The hire aims to strengthen Lazard's presence in the DACH region and engage with Swiss corporate and financial communities. Lazard projects $4.6 billion revenue and $573.6 million earnings by 2029, requiring 12.6% yearly revenue growth. The company recently increased its share repurchase authorization by $200 million, despite softer Q2 2026 earnings. Analysts have mixed

$LAZMed

Lazard, Inc. Q2 2026: Revenue $807.7M, EPS $0.03— 10-Q Summary

Lazard, Inc. (LAZ) reported Q2 2026 revenue of $807.7M, up 1% year over year, but profitability fell. Net income attributable to Lazard was $4.8M versus $55.3M a year earlier, and diluted EPS was $0.03 versus $0.52. Adjusted net revenue rose modestly as Asset Management gains offset weaker Financial Advisory fees. Lazard agreed to acquire Campbell Lutyens, with potential earnouts totaling about $660M+, expected to close in 2H 2026.

$LAZMed

Lazard Poaches From Goldman, AllianceBernstein for Asset Manager

Lazard Asset Management hired Chris Hogbin’s team, adding TP Enders from Goldman Sachs as head of product and Christopher Bricker from AllianceBernstein to lead corporate development. The moves follow Lazard reporting record client assets and $7.4 billion of first-half inflows, despite a $1.4 billion May withdrawal that cut Lazard shares about 13% on disclosure. Lazard oversees $285 billion.